US FDA Wants More Generic-Specific Experience In Next OGD Director
Vacancy notice includes preferences for candidates with experience formulating generic drug policy and strategy, as well as in overall drug development, which is intended to make the search more efficient.
You may also be interested in...
US FDA Implementing Hybrid Work Policy In January
Agency employees will have on-site, telework and remote possibilities, but options will depend on the center, office and job duties.
US FDA’s New Acting Generics Chief Relearning System After 24 Years Of Experience
Acting OGD Director Susan Rosencrance says in an interview that the generics assessment system has evolved substantially since she moved to the Office of Pharmaceutical Quality in 2015.
New Name, Old Problems: US FDA’s Cell And Gene Therapy Office Still Facing Growth Challenges
The group will be called the Office of Therapeutic Products, but needs more people to handle its increasing workload.